Update on metformin for osteoarthritis treatment
Inflammopharmacology · 2025
DOI: 10.1007/s10787-025-01902-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammopharmacology, 2025. Verfasst von Ben-Zheng Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College of Gansu, University of Traditional Chinese Medicine, Lanzhou, China. Hauptthemen laut MEDLINE: Metformin, Osteoarthritis, Metabolic Syndrome, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben.
Abstract (Originalsprache)
Osteoarthritis (OA) is a prevalent degenerative joint disease among middle-aged and elderly individuals. Metabolic syndrome (Met S), a group of clinical conditions characterized by abnormal metabolic processes, includes obesity as one of its primary risk factors. Recent studies have demonstrated a significant association between metabolic syndrome and osteoarthritis. Metformin, a classical hypoglycemic agent, is commonly prescribed for patients with type 2 diabetes mellitus who do not achieve adequate control through diet and physical activity alone. Metformin has gradually gained attention in the treatment of OA due to its anti-inflammatory, antioxidant, and metabolic function-enhancing properties. This review summarizes the latest research on metformin by examining recent clinical and animal studies, systematically analyzing its mechanisms, and assessing its clinical potential in treating OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Clinical Medical College of Gansu, University of Traditional Chinese Medicine, Lanzhou, China.
- People's Hospital of Gansu Province, 204 Donggang West Road, Chengguan District, Lanzhou, 730000, China.
- People's Hospital of Gansu Province, 204 Donggang West Road, Chengguan District, Lanzhou, 730000, China. g_hz@163.com.
Zitieren
APA
Li, B. Z., Wei, H. X., Li, S. Z., Yang, Y. Z., Zhang, A. R., & Guo, H. Z. (2025). Update on metformin for osteoarthritis treatment. Inflammopharmacology. https://doi.org/10.1007/s10787-025-01902-y
Vancouver
Li BZ, Wei HX, Li SZ, Yang YZ, Zhang AR, Guo HZ. Update on metformin for osteoarthritis treatment. Inflammopharmacology. 2025. doi:10.1007/s10787-025-01902-y
BibTeX
@article{Li2025,
author = {Li, Ben-Zheng and Wei, He-Xin and Li, Shu-Zhi and Yang, Yong-Ze and Zhang, An-Ren and Guo, Hong-Zhang},
title = {Update on metformin for osteoarthritis treatment},
journal = {Inflammopharmacology},
year = {2025},
doi = {10.1007/s10787-025-01902-y}
}
EUVIMED